{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:31:42Z","timestamp":1792009902522,"version":"4.4.0"},"reference-count":55,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Diabetic retinopathy (DR) is a leading cause of vision loss globally and represents one of the most common microvascular complications of diabetes. In addition to metabolic disturbances associated with hyperglycemia, oxidative stress has emerged as a critical contributor to the onset and progression of DR. Oxidative stress, defined as an imbalance between the production of reactive oxygen species (ROS) and antioxidant defense mechanisms, leads to cellular injury, inflammation, and increased vascular permeability. In the diabetic retina, excessive ROS production promotes endothelial cell apoptosis, breakdown of the blood-retinal barrier (BRB), and induction of angiogenic factors such as vascular endothelial growth factor (VEGF). This review provides a comprehensive overview of the pathophysiology of DR, focusing on the molecular mechanisms of oxidative stress. Relevant studies were identified through a structured search of PubMed, Web of Science, and Scopus (2000\u20132025) using terms such as \u2018diabetic retinopathy\u2019, \u2018oxidative stress\u2019, and \u2018antioxidants\u2019. We explore current knowledge on oxidative stress-related biomarkers and therapeutic strategies targeting oxidative damage, including antioxidant compounds and mitochondrial protective agents. Recent findings from both experimental and clinical studies are summarized, highlighting the translational potential of oxidative stress modulation in DR management. Finally, future research directions are discussed, including biomarker standardization, personalized medicine approaches, and long-term clinical validation of antioxidant-based therapies. A deeper understanding of oxidative stress may offer valuable insights into novel diagnostic and therapeutic strategies for DR.<\/jats:p>","DOI":"10.3390\/antiox14101204","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T08:10:51Z","timestamp":1759738251000},"page":"1204","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Oxidative Stress in Diabetic Retinopathy: A Comprehensive Review of Mechanisms, Biomarkers, and Therapeutic Perspectives"],"prefix":"10.3390","volume":"14","author":[{"given":"Tatsuya","family":"Mimura","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, School of Dental Medicine, Tsurumi University, Yokohama 230-0063, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6925-3063","authenticated-orcid":false,"given":"Hidetaka","family":"Noma","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tokyo Medical University Ibaraki Medical Center, Ami-cho 300-0395, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"ref_2","unstructured":"International Diabetes Federation (2025). IDF Diabetes Atlas, International Diabetes Federation. [11th ed.]. Available online: https:\/\/diabetesatlas.org."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1113\/expphysiol.1997.sp004024","article-title":"Oxidative stress: Oxidants and antioxidants","volume":"82","author":"Sies","year":"1997","journal-title":"Exp. Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0278-5846(03)00023-X","article-title":"A new view of diabetic retinopathy: A neurodegenerative disease of the eye","volume":"27","author":"Barber","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"43603","DOI":"10.1155\/2007\/43603","article-title":"Oxidative stress and diabetic retinopathy","volume":"2007","author":"Kowluru","year":"2007","journal-title":"Exp. Diabetes Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"104924","DOI":"10.1016\/j.phrs.2020.104924","article-title":"Hypoxia-inducible factor-1\u03b1: A promising therapeutic target for vasculopathy in diabetic retinopathy","volume":"159","author":"Li","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1096\/fj.01-0707fje","article-title":"Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression","volume":"16","author":"Joussen","year":"2002","journal-title":"FASEB J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2174\/1389450054021981","article-title":"Vascular endothelial growth factor and diabetic retinopathy: Role of oxidative stress","volume":"6","author":"Caldwell","year":"2005","journal-title":"Curr. Drug Targets"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00125-006-0174-y","article-title":"Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy","volume":"49","author":"Lin","year":"2006","journal-title":"Diabetologia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4103\/1673-5374.266910","article-title":"Neuroinflammation and oxidative stress act in concert to promote neurodegeneration in the diabetic retina and optic nerve: Galectin-3 participation","volume":"15","author":"Mendonca","year":"2020","journal-title":"Neural Regen. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.lfs.2016.02.002","article-title":"Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies","volume":"148","author":"Rani","year":"2016","journal-title":"Life Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1089\/ars.2005.7.1581","article-title":"Diabetic retinopathy: Mitochondrial dysfunction and retinal capillary cell death","volume":"7","author":"Kowluru","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tem.2013.09.005","article-title":"Neurodegeneration in the diabetic eye: New insights and therapeutic perspectives","volume":"25","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.lfs.2004.10.017","article-title":"Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions","volume":"76","author":"Kowluru","year":"2005","journal-title":"Life Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.bbadis.2015.08.001","article-title":"Oxidative stress, mitochondrial damage and diabetic retinopathy","volume":"1852","author":"Kowluru","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.freeradbiomed.2011.08.017","article-title":"Mitochondrial biogenesis and the development of diabetic retinopathy","volume":"51","author":"Santos","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1096\/fj.05-4313fje","article-title":"Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor","volume":"20","author":"Zhang","year":"2006","journal-title":"FASEB J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"9702820","DOI":"10.1155\/2017\/9702820","article-title":"Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy","volume":"2017","author":"Li","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/jnen\/59.12.1094","article-title":"Neurotoxicity of advanced glycation end-products for cultured cortical neurons","volume":"59","author":"Takeuchi","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1167\/iovs.08-1755","article-title":"Role of NADPH oxidase in retinal vascular inflammation","volume":"49","author":"Rojas","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7480","DOI":"10.3390\/ijms14047480","article-title":"Soluble receptor for advanced glycation end-product (sRAGE)\/pentosidine ratio: A potential risk factor determinant for type 2 diabetic retinopathy","volume":"14","author":"Ng","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/CM9.0000000000002620","article-title":"Malondialdehyde levels in diabetic retinopathy patients: A systematic review and meta-analysis","volume":"136","author":"Jiang","year":"2023","journal-title":"Chin. Med. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2337\/diacare.23.2.234","article-title":"Serum markers of oxidative stress and severity of diabetic retinopathy","volume":"23","author":"Hartnett","year":"2000","journal-title":"Diabetes Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1159\/000514722","article-title":"Role of oxidative stress and severity of diabetic retinopathy in type 1 and type 2 diabetes","volume":"64","author":"Bokhary","year":"2021","journal-title":"Ophthalmic Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1167\/iovs.05-1276","article-title":"Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy","volume":"47","author":"Kowluru","year":"2006","journal-title":"Investig. Ophthalmol Vis Sci."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Garcia-Medina, J.J., Rubio-Velazquez, E., Foulquie-Moreno, E., Casaroli-Marano, R.P., Pinazo-Duran, M.D., Zanon-Moreno, V., and Del-Rio-Vellosillo, M. (2020). Update on the effects of antioxidants on diabetic retinopathy: In vitro experiments, animal studies and clinical trials. Antioxidants, 9.","DOI":"10.3390\/antiox9060561"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1442-9071.2009.02000.x","article-title":"Effect of N-acetylcysteine on the early expression of inflammatory markers in the retina and plasma of diabetic rats","volume":"37","author":"Tsai","year":"2009","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"8837893","DOI":"10.1155\/2020\/8837893","article-title":"Mitochondria-targeted antioxidants: A step towards disease treatment","volume":"2020","author":"Jiang","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2337\/db17-0996","article-title":"Sirt1: A guardian of the development of diabetic retinopathy","volume":"67","author":"Mishra","year":"2018","journal-title":"Diabetes"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S2213-8587(14)70256-6","article-title":"Effects of RAS inhibitors on diabetic retinopathy: A systematic review and meta-analysis","volume":"3","author":"Wang","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/jnnp-2012-304792","article-title":"Mediterranean diet improves cognition: The PREDIMED-NAVARRArandomised trial","volume":"84","author":"Clavero","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Su, Z., Wu, Z., Liang, X., Xie, M., Xie, J., Li, H., Wang, X., and Jiang, F. (2023). Diabetic Retinopathy Risk in Patients with Unhealthy Lifestyle: A Mendelian Randomization Study. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1087965"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Haydinger, C.D., Oliver, G.F., Ashander, L.M., and Smith, J.R. (2023). Oxidative stress and its regulation in diabetic retinopathy. Antioxidants, 12.","DOI":"10.3390\/antiox12081649"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1167\/iovs.14-15687","article-title":"Oxidative stress and light-evoked responses of the posterior segment in a mouse model of diabetic retinopathy","volume":"56","author":"Berkowitz","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5407482","DOI":"10.1155\/2018\/5407482","article-title":"Curcumin modulates DNA methyltransferase functions in a cellular model of diabetic retinopathy","volume":"2018","author":"Maugeri","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Jim\u00e9nez, V., Burggraaf-S\u00e1nchez de las Matas, R., and Ortega, \u00c1.L. (2025). Modulation of oxidative stress in diabetic retinopathy: Therapeutic role of natural polyphenols. Antioxidants, 14.","DOI":"10.3390\/antiox14070875"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12967-025-06110-4","article-title":"Oxidative stress and retinopathy: Evidence from epidemiological studies","volume":"23","author":"Liu","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"He, W., Tang, P., and Lv, H. (2025). Targeting oxidative stress in diabetic retinopathy: Mechanisms, pathology, and novel treatment approaches. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1571576"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1538\/expanim.21-0122","article-title":"Retinal Src homology region 2-containing protein tyrosine phosphatase 2 silencing alleviates diabetic retinopathy via suppressing inflammatory response and oxidative stress by regulating Yes-associated protein 1 activity","volume":"71","author":"Han","year":"2022","journal-title":"Exp. Anim."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1076\/ceyr.21.4.814.5545","article-title":"Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine","volume":"21","author":"Kowluru","year":"2000","journal-title":"Curr. Eye Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jdiacomp.2011.11.004","article-title":"Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy","volume":"26","author":"Ola","year":"2012","journal-title":"J. Diabetes Complicat."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.2337\/diabetes.53.12.3233","article-title":"Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats","volume":"53","author":"Kowluru","year":"2004","journal-title":"Diabetes"},{"key":"ref_50","first-page":"406","article-title":"Effect of lutein supplementation on visual function in nonproliferative diabetic retinopathy","volume":"26","author":"Zhang","year":"2017","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"637","DOI":"10.5301\/EJO.2010.6212","article-title":"A 5-year follow-up of antioxidant supplementation in type 2 diabetic retinopathy","volume":"21","year":"2011","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jsfa.3785","article-title":"Effects of lutein and zeaxanthin on aspects of eye health","volume":"90","author":"Ma","year":"2010","journal-title":"J. Sci. Food Agric."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1017\/S0007114511000316","article-title":"Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients","volume":"106","author":"Laczy","year":"2011","journal-title":"Br. J. Nutr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3109\/10715762.2012.692787","article-title":"Genetic polymorphisms of antioxidant enzymes as risk factors for oxidative stress-associated complications in preterm infants","volume":"46","author":"Giusti","year":"2012","journal-title":"Free Radic. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"982502","DOI":"10.1155\/2020\/9825028","article-title":"Genetic polymorphism of the Nrf2 promoter region (rs35652124) is associated with the risk of diabetic foot ulcers","volume":"2020","author":"Teena","year":"2020","journal-title":"Oxid. Med. Cell. Longev."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/10\/1204\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T08:28:28Z","timestamp":1759739308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/10\/1204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":55,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["antiox14101204"],"URL":"https:\/\/doi.org\/10.3390\/antiox14101204","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,4]]}}}